Non-alcoholic fatty liver disease: clinical review
Content developed by MIMS Learning https://www.mimslearning.co.uk/
The current obesity epidemic has led to a sharp increase in the incidence and prevalence of non-alcoholic fatty liver disease (NAFLD). This resource covers the diagnosis and management of NAFLD, which is predicted to overtake hepatitis C to become the leading cause of liver transplantation. Although the majority of investigation and treatment will be carried in secondary care, the most important initial step in management is to encourage weight loss. Key learning points include suitable investigations, non-invasive assessment, new treatments and prognosis.
After completing this module, you should be better able to:
Rebeca Carter, Angelina Mouralidarane, Dr Junpei Soeda and Dr Jude Oben, University College London and Royal Free Hospital, London and Dr Shuvra Ray, Guy's and St Thomas' Hospital, London.
This resource is provided at an advanced level by MIMS Learning. Read the article and reflect on what you have learned, then answer the test questions at the end.
Complete the resource to obtain a certificate of completion to include in your revalidation portfolio. You should record the time spent on this resource in your CPD log.